Literature DB >> 22648223

Efficacy and safety of a ceramide containing moisturizer followed by fixed-dose clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel in the morning in combination with a ceramide containing moisturizer followed by tretinoin 0.05% gel in the evening for the treatment of facial acne vulgaris.

Joshua A Zeichner1, Rita V Patel, Madelaine Haddican, Vicky Wong.   

Abstract

Combination therapy addressing multiple pathogenic factors should be used to achieve optimal outcomes in treating acne. The following study demonstrated both safety and efficacy of fixed-dose clindamycin phosphate 1.2%/benzoyl peroxide 2.5% in the morning with micronized tretinoin 0.05% gel in the evening. Both products were applied to the skin following the use of a ceramide containing moisturizing lotion.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22648223

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  4 in total

Review 1.  Multivesicular Emulsion Ceramide-containing Moisturizers: An Evaluation of Their Role in the Management of Common Skin Disorders.

Authors:  Joshua A Zeichner; James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2016-12-01

Review 2.  Emerging Issues in Adult Female Acne.

Authors:  Joshua A Zeichner; Hillary E Baldwin; Fran E Cook-Bolden; Lawrence F Eichenfield; Sheila Fallon-Friedlander; David A Rodriguez
Journal:  J Clin Aesthet Dermatol       Date:  2017-01-01

Review 3.  Effects of Topical Retinoids on Acne and Post-inflammatory Hyperpigmentation in Patients with Skin of Color: A Clinical Review and Implications for Practice.

Authors:  Valerie D Callender; Hilary Baldwin; Fran E Cook-Bolden; Andrew F Alexis; Linda Stein Gold; Eric Guenin
Journal:  Am J Clin Dermatol       Date:  2021-11-09       Impact factor: 7.403

Review 4.  The Synergy between Pharmacological Regimens and Dermocosmetics and Its Impact on Adherence in Acne Treatment.

Authors:  Elena Araviiskaia; Alison Margaret Layton; Jose Luis López Estebaranz; Falk Ochsendorf; Giuseppe Micali
Journal:  Dermatol Res Pract       Date:  2022-08-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.